THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) Files An 8-K Results of Operations and Financial ConditionItem 2.02 Results of Operations and Financial Condition
THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) Files An 8-K Results of Operations and Financial Condition
On April 26, 2017, the Registrant announced its financial results for the fiscal quarter ended April 1, 2017. The full text of the press release issued in connection with the announcement is attached as Exhibit 99.1 to this Form 8-K and incorporated herein by reference.
The information contained in Item 2.02 of this Form 8-K (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”) or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as expressly set forth by specific reference in such a filing.
Item 9.01 Financial Statements and Exhibits
(d) Exhibits
The following Exhibit relating to Item 2.02 shall be deemed “furnished,” and not “filed”:
99.1 Press Release dated April 26, 2017
THERMO FISHER SCIENTIFIC INC.
About THERMO FISHER SCIENTIFIC INC. (NYSE:TMO)
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Through the Life Sciences Solutions segment, it provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of disease. Through the Analytical Instruments segment, it provides instruments, consumables, software and services. The Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers self-manufactured and sourced products for the laboratory. THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) Recent Trading Information
THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) closed its last trading session up +1.47 at 158.81 with 2,171,285 shares trading hands.
Thermo Fisher Scientific Inc. develops, manufactures and sells a range of products. The Company is a provider of analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. The company operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services. Through the Life Sciences Solutions segment, it provides reagents, instruments and consumables used in biological and medical research, discovery and production of new drugs and vaccines, as well as diagnosis of disease. Through the Analytical Instruments segment, it provides instruments, consumables, software and services. The Specialty Diagnostics segment offers diagnostic test kits, reagents, culture media, instruments and associated products. The Laboratory Products and Services segment offers self-manufactured and sourced products for the laboratory. THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) Recent Trading Information
THERMO FISHER SCIENTIFIC INC. (NYSE:TMO) closed its last trading session up +1.47 at 158.81 with 2,171,285 shares trading hands.
